Hopkinton-based biotechnology company Caliper Life Sciences swung to a $3.2 million loss during the second quarter despite revenues increasing 32 percent year-over-year to $38.3 million.
Last year the company recorded a $9 million profit during the second quarter after it divested one of its specialty products businesses. This year, without that one-time windfall on the books, the company swung to a loss.
For the first half of the year, the company lost $5.8 million on $74 million in revenues. That’s compared to a $7 million profit on only $57 million in revenues through the first half of last year.
The company’s operating expenses rose by 27 percent after the integration of Cambridge Research & Instrumentation, which the company bought late last year.
